Germany Metagenomics Market Size & Outlook, 2023-2030
Germany metagenomics market, 2018-2030 (US$M)
Related Markets
Germany metagenomics market highlights
- The Germany metagenomics market generated a revenue of USD 125.3 million in 2023 and is expected to reach USD 309.8 million by 2030.
- The Germany market is expected to grow at a CAGR of 13.8% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.
Metagenomics market data book summary
| Market revenue in 2023 | USD 125.3 million |
| Market revenue in 2030 | USD 309.8 million |
| Growth rate | 13.8% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Sequencing & Data Analytics Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Sequencing & Data Analytics Services, Software |
| Key market players worldwide | Bio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG |
Other key industry trends
- In terms of revenue, Germany accounted for 6.2% of the global metagenomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany metagenomics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 251.6 million by 2030.
Kits & reagents was the largest segment with a revenue share of 61.53% in 2023. Horizon Databook has segmented the Germany metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.
A large number of providers are offering NGS tools and undertaking initiatives to expand the scope of these tools. QIAGEN, CeGaT GmbH, Intrexon Bioinformatics Germany GmbH, and Eurofins Scientific are some of the companies significantly impacting the market growth in this region. For instance, in May 2022, QIAGEN N.V. launched QIAxcel Connect, a nucleic acid analysis capillary electrophoresis instrument.
This device is used for high-resolution genotyping and QC of cell-free DNA & NGS library. In addition, in January 2021, Eurofins Scientific expanded its capacity for assessment and detection of novel COVID-19 strains. The capacity expansion included ARTIC NGS of more than 5,000 full genomes per day. Several initiatives undertaken in this country to expand the scope of genomic studies drive the uptake of sequencing solutions.
For instance, in January 2020, Germany joined the 1+Million Genomes Initiative, declaring its intent to enable access to at least 1 million sequenced genomes in the EU by 2022. It aimed to enhance disease prevention and scale up clinical research for personalized treatments.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Metagenomics Market Scope
Metagenomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany metagenomics market size, by product, 2018-2030 (US$M)
Germany Metagenomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
